Ticagrelor Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a trusted Ticagrelor Tablets Manufacturer in India manufacturing antiplatelet formulations for cardiovascular risk reduction and clot prevention therapies.

The formulation is widely prescribed in acute coronary syndrome and post-cardiac event management where inhibition of platelet aggregation is clinically important for prevention of thrombotic complications. The company also serves as an Antiplatelet Tablets Exporter for regulated international cardiovascular pharmaceutical markets.

Genliva Wellness LLP further operates as a Blood Clot Prevention Medicine Supplier providing contract manufacturing, private labeling, and export supply services for cardiovascular healthcare distributors and hospital pharmaceutical procurement companies.

Ticagrelor Tablets are formulated for antiplatelet and vascular protection therapy.

Oral antiplatelet pharmaceutical formulation
Frequently utilized in cardiovascular risk management
Supports platelet aggregation inhibition therapies

This formulation is prescribed in cardiovascular management therapies.

Prevention of blood clot formation
Management of acute coronary syndrome conditions
Administered in cardiovascular protection therapies
Utilized in thrombotic risk reduction management

Ticagrelor Tablets deliver vascular protection support for cardiovascular management.

Valuable in clot prevention management
Frequently preferred in coronary care therapy
Effective platelet inhibition support
Useful in long-term cardiovascular management
Convenient oral antiplatelet administration
Maintains reliable vascular therapeutic performance